Corpay, Inc. CPAY | NYSE

$326.58 $3.93 | 1.22%

Next Earnings: May 06, 2025

Company Overview:

Market Cap: $22.94B
PE Ratio: 23.38
52-Week Range: $247.10 - $400.81

6 Year Performance Metrics:

Total Return (with DRIP): 25.50% (3.86% / yr)
Total Return (no DRIP): 25.50% (3.86% / yr)
Share Price: 25.50%
CPAY Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CPAY Earnings, Revenue, Cash & Debt, Shares Outstaning:

CPAY - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CPAY - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CPAY - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CPAY - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CPAY - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CPAY - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CPAY - Revenue
14-Day FREE Trial Get Full Access Now!
CPAY Revenue CAGR:1Y: 10.36%2Y: 8.20%5Y: 8.16%10Y: 10.63%
CPAY - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CPAY EPS CAGR:1Y: -1.15%2Y: 6.55%5Y: 5.76%10Y: 11.01%
CPAY - Net Income
14-Day FREE Trial Get Full Access Now!
CPAY Net Income CAGR:1Y: -3.87%2Y: 4.48%5Y: 0.87%10Y: 8.42%
CPAY - EBITDA
14-Day FREE Trial Get Full Access Now!
CPAY EBITDA CAGR:1Y: 12.79%2Y: 10.71%5Y: 10.25%10Y: 12.91%
CPAY - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CPAY Free Cash Flow CAGR:1Y: -100.00%2Y: -100.00%5Y: 0.00%10Y: 0.00%
CPAY - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CPAY Free Cash Flow / Share CAGR:1Y: -100.00%2Y: -100.00%5Y: 0.00%10Y: 0.00%
CPAY - Gross Profit
14-Day FREE Trial Get Full Access Now!
CPAY Gross Profit CAGR:1Y: 40.57%2Y: 32.08%5Y: 13.35%10Y: 13.67%
CPAY - Expenses
14-Day FREE Trial Get Full Access Now!
CPAY Expenses CAGR:1Y: -100.00%2Y: -100.00%5Y: 0.00%10Y: 0.00%
CPAY - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CPAY Shares Outstanding CAGR:1Y: -2.74%2Y: -1.89%5Y: -4.60%10Y: -2.31%
CPAY - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CPAY Share Buybacks CAGR:1Y: -100.00%2Y: -100.00%5Y: 0.00%10Y: 0.00%
CPAY - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CPAY Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: 0.00%10Y: 0.00%
CPAY - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CPAY Revenue CAGR:1Y: 10.36%2Y: 8.20%5Y: 8.16%10Y: 10.63%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CPAY - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CPAY Actual Revenue CAGR:1Y: 10.36%2Y: 8.20%5Y: 8.16%10Y: 10.63%
CPAY - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CPAY Actual EPS CAGR:1Y: -1.15%2Y: 6.55%5Y: 5.76%10Y: 11.01%
CPAY - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CPAY Actual Net Income CAGR:1Y: -3.87%2Y: 4.48%5Y: 0.87%10Y: 8.42%
CPAY - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CPAY Actual EBITDA CAGR:1Y: 12.79%2Y: 10.71%5Y: 10.25%10Y: 12.91%

Ratios, Profit Margins & Return on Capital:

CPAY - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CPAY Net Profit Margin CAGR:1Y: -12.89%2Y: -3.43%5Y: 0.00%10Y: 0.00%
CPAY - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CPAY Gross Profit Margin CAGR:1Y: 27.37%2Y: 22.07%5Y: 0.00%10Y: 0.00%
CPAY - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CPAY - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CPAY - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CPAY - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for CPAY

Based on past 6-year performance, here are CPAY growth metrics:

Share price CAGR of +3.86%
Dividend CAGR of +0%

Using CPAY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CPAY (DRIP)CPAY - No DRIP
Current Price$322.65$322.65
Start Shares30.9930.99
Start Value$10,000$10,000
  
After 10 years:
Final Share Count30.9930.99
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$453.63$322.65
Total Dividends$0$0
Final Value$14,059$10,000

Estimated Future Value + Dividends - CPAY

NOTE: Above numbers are our estimate based on CPAY's Dividend and Price CAGR over past 6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Corpay, Inc. (CPAY) had its IPO on , and is trader on NYSE stock exchange.

Website - not listed.


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial